Grafa News and Videos — Page 18

Intelligent Bio Solutions (NASDAQ:INBS) reported fiscal 2026 revenue of $4.2 million, up 38% year over year, driven by growth in its installed reader base and consumable cartridge sales.

Chemomab Therapeutics (NASDAQ:CMMB) reported second-quarter 2026 results and progress on its proposed all-stock merger with Scipher Medicine, with Chemomab shareholders expected to own about 32% of a combined company valued at $150 million.

Galmed Pharmaceuticals (NASDAQ:GLMD) announced that its wholly owned subsidiary Colospan completed a first-in-human feasibility study of a colon tissue quality assessment platform in 32 colorectal cancer patients undergoing elective surgery.

Veralto (NYSE:VLTO) signed a definitive agreement to acquire Cleanwater1 for $465 million, with an estimated net purchase price of $452 million after tax benefits.

Datavault AI (NASDAQ:DVLT) reported second-quarter 2026 revenue of $6.7 million, up $5 million or 287% year over year, as the company expanded its data monetization and tokenization platforms.

Antalpha (NASDAQ:ANTA) reported unaudited second-quarter 2026 revenue of $12.2 million, down 28% year over year, mainly due to lower technology financing fees following the wind-down of the Cango facility.

Viking Holdings (NYSE:VIK) reported second-quarter 2026 revenue of $2.19 billion, up 16.5% year over year, with adjusted EBITDA increasing 18.2% to $748.4 million.

TJX Companies (NYSE:TJX) reported second-quarter fiscal 2027 net sales of $15.2 billion, up 5% year over year, with consolidated comparable sales increasing 4%.

ZIM Integrated Shipping Services (NYSE:ZIM) reported second-quarter 2026 revenue of $1.78 billion, up 9% year over year, with net income increasing to $64 million from $24 million.

Aurora Cannabis (NASDAQ:ACB) confirmed that Curaleaf Holdings has commenced an unsolicited takeover bid for all Aurora common shares, offering implied consideration of US$4 per share.